Bladder preserving approach for muscle invasive bladder cancer--role of mycobacterium w.
J Indian Med Assoc
;
2003 Sep; 101(9): 559-60
Artículo
en Inglés
| IMSEAR
| ID: sea-103727
ABSTRACT
Mycobacterium w (immuvac), a new potent immunomodulator was evaluated as concomitant therapy in the management of muscle invasive bladder cancer along with external beam radiation therapy. There was no residual tumour in all the five patients after two months of therapy. All patients remained disease free for an observation period of more than 2 years.
Texto completo:
Disponible
Índice:
IMSEAR (Asia Sudoriental)
Asunto principal:
Neoplasias de la Vejiga Urinaria
/
Femenino
/
Humanos
/
Masculino
/
Vacunas Bacterianas
/
Carcinoma de Células Transicionales
/
Proyectos Piloto
/
Terapia Combinada
/
Persona de Mediana Edad
/
Músculo Liso
Idioma:
Inglés
Revista:
J Indian Med Assoc
Año:
2003
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS